Machine Learning-Based Multimodel Computing for Medical Imaging for Classification and Detection of Alzheimer Disease

Abstract

Alzheimer is a disease that causes the brain to deteriorate over time. It starts off mild, but over the course of time, it becomes increasingly more severe. Alzheimer’s disease causes damage to brain cells as well as the death of those cells. Memory in humans is especially susceptible to this. Memory loss is the first indication of Alzheimer’s disease, but as the disease progresses and more brain cells die, additional symptoms arise. Medical image processing entails developing a visual portrayal of the inside of a body using a range of imaging technologies in order to discover and cure problems. This paper presents machine learning-based multimodel computing for medical imaging for classification and detection of Alzheimer disease. Images are acquired first. MRI images contain noise and contrast problem. Images are preprocessed using CLAHE algorithm. It improves image quality. CLAHE is better to other methods in its capacity to enhance the look of mammography in minute places. A white background makes the lesions more obvious to the naked eye. In spite of the fact that this method makes it simpler to differentiate between signal and noise, the images still include a significant amount of graininess. Images are segmented using the k-means algorithm. This results in the segmentation of images and identification of region of interest. Useful features are extracted using PCA algorithm. Finally, images are classified using machine learning algorithms.

Comparative Evaluation of Machine Learning Models for Subtyping Triple-Negative Breast Cancer: A Deep Learning-Based Multi-Omics Data Integration Approach

“…The fused image was then standardized by scaling the pixel values to the range of [0-1], achieved by dividing each pixel value by 255. This approach ensured uniform model input sizing and mitigates the noise present in the external image, addressing the issue of intensity heterogeneity in MRI to ensure the correct learning of head image segmentation information by the model 27 , resulting in improved robustness and accuracy of the Mask R-CNN model 28 .…”

Assessment for Alzheimer’s Disease Advancement Using Classification Models with Rules

“…While pathological assessments of Alzheimer's disease (AD) diagnosis, such as using biological markers (biomarkers), and magnetic resonance imaging (MRI) [5] can be used to predict the disease, they are also time-and cost-intensive, stressful, and provide results requiring laboratory study and professional personnel who may not be available [6][7][8]. Therefore, cognitive assessments used for prodromal dementia such as the Alzheimer's Disease Assessment Scale-Cognitive 13 (ADAS-Cog-13), Mini Mental State Examination (MMSE), and others [9,10] are useful since they can screen for signs of early impairment.…”